On the public citation graph
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
0 signed · 117 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/adfm.201404629openalex-snapshot
Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer
inferredcites →https://doi.org/10.1002/adma.201205292openalex-snapshot
In Vivo Bio‐Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles
inferredcites →https://doi.org/10.1002/anie.201310709openalex-snapshot
A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
inferredcites →https://doi.org/10.1002/jcb.26254openalex-snapshot
The application of aptamer 5TR1 in triple negative breast cancer target therapy
inferredcites →https://doi.org/10.1002/med.20238openalex-snapshot
Targeted Drug Delivery and Penetration Into Solid Tumors
inferredcites →https://doi.org/10.1002/open.201600072openalex-snapshot
Hyperbranched Polyglycerol‐Induced Porous Silica Nanoparticles as Drug Carriers for Cancer Therapy In Vitro and In Vivo
inferredcites →https://doi.org/10.1002/smll.200900923openalex-snapshot
Intracellular Localization and Cytotoxicity of Spherical Mesoporous Silica Nano‐ and Microparticles
inferredcites →https://doi.org/10.1002/smll.201600550openalex-snapshot
The Architecture and Function of Monoclonal Antibody‐Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention
inferredcites →https://doi.org/10.1007/s10616-016-0056-1openalex-snapshot
Lithium chloride promotes neuronal differentiation of rat neural stem cells and enhances neural regeneration in Parkinson’s disease model
inferredcites →https://doi.org/10.1007/s10637-011-9670-0openalex-snapshot
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
inferredcites →https://doi.org/10.1016/j.actbio.2015.01.002openalex-snapshot
Specific aptamer-conjugated mesoporous silica–carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy
inferredcites →https://doi.org/10.1016/j.addr.2013.11.009openalex-snapshot
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
inferredcites →https://doi.org/10.1016/j.bios.2016.06.024openalex-snapshot
A self-assembling RNA aptamer-based graphene oxide sensor for the turn-on detection of theophylline in serum
inferredcites →https://doi.org/10.1016/j.clml.2015.12.004openalex-snapshot
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
inferredcites →https://doi.org/10.1016/j.ejps.2015.12.014openalex-snapshot
EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
inferredcites →https://doi.org/10.1016/j.humpath.2003.08.026openalex-snapshot
Frequent EpCam protein expression in human carcinomas
inferredcites →https://doi.org/10.1016/j.ijpharm.2013.12.045openalex-snapshot
Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release
inferredcites →https://doi.org/10.1016/j.jcis.2015.11.001openalex-snapshot
Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy
inferredcites →https://doi.org/10.1021/ac400366bopenalex-snapshot
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
inferredcites →https://doi.org/10.1021/am501337sopenalex-snapshot
Effect of pH-Responsive Alginate/Chitosan Multilayers Coating on Delivery Efficiency, Cellular Uptake and Biodistribution of Mesoporous Silica Nanoparticles Based Nanocarriers
inferredcites →https://doi.org/10.1021/ja00759a054openalex-snapshot
Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
inferredcites →https://doi.org/10.1021/nn405809copenalex-snapshot
Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers
inferredcites →https://doi.org/10.1038/ncomms13019openalex-snapshot
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
inferredcites →https://doi.org/10.1038/sj.bjc.6602924openalex-snapshot
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
inferredcites →https://doi.org/10.1039/c2jm15489gopenalex-snapshot
Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy
inferredcites →https://doi.org/10.1039/c2jm34825jopenalex-snapshot
Antimicrobial effect of polydopamine coating on Escherichia coli
inferredcites →https://doi.org/10.1039/c5nr03527aopenalex-snapshot
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles
inferredcites →https://doi.org/10.1039/c5nr03777hopenalex-snapshot
Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core–shell mesoporous silica nanoparticles
inferredcites →https://doi.org/10.1111/j.1365-2141.2008.07000.xopenalex-snapshot
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901‐DM1): a potential therapeutic modality implication against natural killer/T cell malignancy
inferredcites →https://doi.org/10.1126/science.1147241openalex-snapshot
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0012openalex-snapshot
FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-15-0580openalex-snapshot
Ado-Trastuzumab Emtansine Targets Hepatocytes Via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity
inferredcites →https://doi.org/10.1200/jco.2007.15.0532openalex-snapshot
Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2010.29.5865openalex-snapshot
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
inferredcites →https://doi.org/10.1248/cpb.52.1openalex-snapshot
Recent Developments in the Maytansinoid Antitumor Agents
inferredcites →https://doi.org/10.1371/journal.pone.0075182openalex-snapshot
Ansamitocin P3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site
inferredcites →https://doi.org/10.1371/journal.pone.0117523openalex-snapshot
High-Affinity Accumulation of a Maytansinoid in Cells via Weak Tubulin Interaction
inferredcites →https://doi.org/10.2147/ijn.s112951openalex-snapshot
Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles
inferredcites →https://doi.org/10.2147/ijn.s117495openalex-snapshot
Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook
inferredcites →https://doi.org/10.2147/ijn.s121881openalex-snapshot
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
inferredcites →https://doi.org/10.2147/ijn.s125231openalex-snapshot
Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
inferredcites →https://doi.org/10.2147/ijn.s133166openalex-snapshot
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
inferredcites →https://doi.org/10.3892/or.2014.3313openalex-snapshot
ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer
inferredcites →https://doi.org/10.7150/thno.11389openalex-snapshot
Theranostic Mesoporous Silica Nanoparticles Biodegrade after Pro-Survival Drug Delivery and Ultrasound/Magnetic Resonance Imaging of Stem Cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4856703openalex-extracted
Towards the Preparation of Smart Drug Delivery Platforms for Colorectal Cancer Therapy: Biocompatible and Targeted Mesoporous Silica Nanoparticles with Deferiprone-Copper Complex Gatekeeper
inferred← citeshttps://doi.org/10.1002/btpr.3116openalex-snapshot
Anti‐ epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model
inferred← citeshttps://doi.org/10.1002/mog2.8openalex-snapshot
Tumor immunotherapy: Mechanisms and clinical applications
inferred← citeshttps://doi.org/10.1007/978-3-030-58675-1_111-1openalex-snapshot
Using Smart Mesoporous Silica in Designing Drug Delivery Systems
inferred← citeshttps://doi.org/10.1007/978-3-030-84205-5_111openalex-snapshot
Using Smart Mesoporous Silica in Designing Drug Delivery Systems
inferred← citeshttps://doi.org/10.1007/s00432-023-05331-8openalex-snapshot
A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis
inferred← citeshttps://doi.org/10.1016/b978-0-12-821437-4.00002-5openalex-snapshot
Mesoporous silica-biopolymer-based systems in drug delivery applications
inferred← citeshttps://doi.org/10.1016/b978-0-323-85881-6.00001-4openalex-snapshot
Aptamers as smart ligands for the development of cancer-targeting nanocarriers
inferred← citeshttps://doi.org/10.1016/b978-0-323-85881-6.00017-8openalex-snapshot
Relevance of aptamers as targeting ligands for anticancer therapies
inferred← citeshttps://doi.org/10.1016/b978-0-443-27406-0.00013-7openalex-snapshot
Silica nanoparticles: synthesis, functionalization, properties, and their biomedical applications
inferred← citeshttps://doi.org/10.1016/b978-0-443-36388-7.00011-2openalex-snapshot
Safety, ethical, regulatory issues, and challenges of nanotherapy for antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.apsb.2023.11.029openalex-snapshot
Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.bbagen.2026.130982openalex-snapshot
Innovative approaches in the therapeutic application of EpCAM aptamer for targeted cancer treatment: A review
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2021.01.023openalex-snapshot
Recent advances in the development of nanomedicines for the treatment of ischemic stroke
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.120682openalex-snapshot
Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives
inferred← citeshttps://doi.org/10.1016/j.ccr.2021.213949openalex-snapshot
Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ceramint.2022.01.358openalex-snapshot
Structure, magnetoelectric, and anticancer activities of core-shell Co0·8Mn0.2R0.02Fe1·98O4@BaTiO3 nanocomposites (R = Ce, Eu, Tb, Tm, or Gd)
inferred← citeshttps://doi.org/10.1016/j.cis.2025.103517openalex-snapshot
Unravelling the therapeutic properties of aptamer-modified exosome nanocomposite
inferred← citeshttps://doi.org/10.1016/j.genrep.2020.100896openalex-snapshot
Application of different nanoparticles in the diagnosis of colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.124173openalex-snapshot
Advances in aptamer-mediated targeted delivery system for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jconrel.2018.10.009openalex-snapshot
Application of polydopamine in tumor targeted drug delivery system and its drug release behavior
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105504openalex-snapshot
Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106087openalex-snapshot
Towards the preparation of smart drug delivery platforms for colorectal cancer therapy: Biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107890openalex-snapshot
Functionalized nanocarriers via surface biomolecules ligation for colorectal cancer treatment
inferred← citeshttps://doi.org/10.1016/j.molliq.2021.115417openalex-snapshot
Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review
inferred← citeshttps://doi.org/10.1016/j.mseb.2021.115232openalex-snapshot
Stimuli-responsive organic-inorganic mesoporous silica hybrids: A comprehensive review on synthesis and recent advances
inferred← citeshttps://doi.org/10.1016/j.nantod.2026.103128openalex-snapshot
Single-cell mass cytometry and multiplexed imaging platforms: Biological insight of advanced nanomaterials, nanoparticles, and nanopollutants
inferred← citeshttps://doi.org/10.1016/j.prp.2022.154024openalex-snapshot
The therapeutic effect of exosomes from mesenchymal stem cells on colorectal cancer: Toward cell-free therapy
inferred← citeshttps://doi.org/10.1016/j.trac.2019.115759openalex-snapshot
Aptamer-conjugated mesoporous silica nanoparticles for simultaneous imaging and therapy of cancer
inferred← citeshttps://doi.org/10.1021/acsami.9b07664openalex-snapshot
Facile Incorporation of “Aggregation-Induced Emission”-Active Conjugated Polymer into Mesoporous Silica Hollow Nanospheres: Synthesis, Characterization, Photophysical Studies, and Application in Bioimaging
inferred← citeshttps://doi.org/10.1038/s42003-024-06043-6openalex-snapshot
Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics
inferred← citeshttps://doi.org/10.1039/9781839166136-00451openalex-snapshot
Chemoresponsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Cancer Therapy
inferred← citeshttps://doi.org/10.1039/c7dt04232aopenalex-snapshot
Evaluation of novel platinum( ii ) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application
inferred← citeshttps://doi.org/10.1039/c8tb00462eopenalex-snapshot
Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles
inferred← citeshttps://doi.org/10.1039/d0tb01559hopenalex-snapshot
Core–shell nanostructures: perspectives towards drug delivery applications
inferred← citeshttps://doi.org/10.1039/d1cs00659bopenalex-snapshot
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
inferred← citeshttps://doi.org/10.1039/d1cs01022kopenalex-snapshot
Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application
inferred← citeshttps://doi.org/10.1039/d3pm00027copenalex-snapshot
A comprehensive investigation of the biophysical approach for aptamer functionalized nanoparticles in cancer therapy: a review
inferred← citeshttps://doi.org/10.1039/d5tb00086fopenalex-snapshot
ZIF-8/doxorubicin nanoparticles camouflaged with Cucurbita -derived exosomes for targeted prostate cancer therapy
inferred← citeshttps://doi.org/10.1042/bst20210343openalex-snapshot
Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface
inferred← citeshttps://doi.org/10.1080/17425247.2019.1598375openalex-snapshot
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update
inferred← citeshttps://doi.org/10.1155/2018/4263520openalex-snapshot
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
inferred← citeshttps://doi.org/10.1155/2019/2740923openalex-snapshot
Nanovectors Design for Theranostic Applications in Colorectal Cancer
inferred← citeshttps://doi.org/10.1186/s12943-024-02151-3openalex-snapshot
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
inferred← citeshttps://doi.org/10.1186/s12951-021-01056-3openalex-snapshot
Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy
inferred← citeshttps://doi.org/10.1186/s12951-021-01131-9openalex-snapshot
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
inferred← citeshttps://doi.org/10.1360/tb-2021-1363openalex-snapshot
Biofunctionalized mesoporous silica nanocarriers and the applications in tumor therapy
inferred← citeshttps://doi.org/10.2147/dddt.s246574openalex-snapshot
Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles
inferred← citeshttps://doi.org/10.2147/ijn.s201688openalex-snapshot
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells
inferred← citeshttps://doi.org/10.2174/0122106812373327250509094328openalex-snapshot
Functionalized Mesoporous Silica Nanoparticles for the Delivery of 3,3'-diindolylmethane to Triple-negative Breast Cancer Cells
inferred← citeshttps://doi.org/10.2174/0929867325666181008142831openalex-snapshot
Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges
inferred← citeshttps://doi.org/10.2174/1389201020666190731130001openalex-snapshot
A Review on Targeting Nanoparticles for Breast Cancer
inferred← citeshttps://doi.org/10.2174/1568009621666211206102942openalex-snapshot
Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy
inferred← citeshttps://doi.org/10.2217/nnm-2017-0353openalex-snapshot
Dual Targeting Delivery of MiR-328 By Functionalized Mesoporous Silica Nanoparticles for Colorectal Cancer Therapy
inferred← citeshttps://doi.org/10.3389/fbioe.2022.1095837openalex-snapshot
Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells
inferred← citeshttps://doi.org/10.3389/fnano.2021.699266openalex-snapshot
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
inferred← citeshttps://doi.org/10.3389/fphar.2024.1341773openalex-snapshot
Evaluation of the synergistic effects of curcumin-resveratrol co-loaded biogenic silica on colorectal cancer cells
inferred← citeshttps://doi.org/10.3390/app10010289openalex-snapshot
Therapeutic Potential of Polymer-Coated Mesoporous Silica Nanoparticles
inferred← citeshttps://doi.org/10.3390/cells11010159openalex-snapshot
Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging
inferred← citeshttps://doi.org/10.3390/gels8040232openalex-snapshot
Targeted Cancer Therapy via pH-Functionalized Nanoparticles: A Scoping Review of Methods and Outcomes
inferred← citeshttps://doi.org/10.3390/ijms20215243openalex-snapshot
Present Scenario of Bioconjugates in Cancer Therapy: A Review
inferred← citeshttps://doi.org/10.3390/ijms21239123openalex-snapshot
Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
inferred← citeshttps://doi.org/10.3390/ijms21249696openalex-snapshot
Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles
inferred← citeshttps://doi.org/10.3390/nano10050916openalex-snapshot
Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles
inferred← citeshttps://doi.org/10.3390/nano12122016openalex-snapshot
Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles
inferred← citeshttps://doi.org/10.3390/pharmaceutics14010110openalex-snapshot
Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release
inferred← citeshttps://doi.org/10.3390/pharmaceutics14122561openalex-snapshot
Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
inferred← citeshttps://doi.org/10.3390/pharmaceutics15020447openalex-snapshot
Natural Biopolymers as Smart Coating Materials of Mesoporous Silica Nanoparticles for Drug Delivery
inferred← citeshttps://doi.org/10.37349/emed.2021.00043openalex-snapshot
Emerging nanomaterials for cancer immunotherapy
inferred← citeshttps://doi.org/10.6084/m9.figshare.16800350openalex-snapshot
Additional file 1 of Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.